Skip to content

13F-HR filed by Mohican Financial Management, LLC

Mohican Financial Management, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-01-29, with 30 holding rows worth $24,250,000.

Accession
0001062993-19-000383
Filed
2019-01-29
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 30 entries on the cover page, a total value of $24,250,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $24,249,000 with VALUE read as thousands by filing date, 13F file number 028-12023. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CARBONITE INC141337AB1NOTE 2.500% 4/02,000,000$2,387,000thousands by filing date
SILICON LABORATORIES INC826919AB8NOTE 1.375% 3/01,500,000$1,589,000thousands by filing date
KAMAN CORP483548AF0BOND1,424,000$1,513,000thousands by filing date
SERVICENOW INC81762PAC6NOTE 6/01,000,000$1,403,000thousands by filing date
HELIX ENERGY SOLUTIONS GRP I42330PAJ6NOTE 4.125% 9/11,500,000$1,374,000thousands by filing date
HARMONIC INC413160AB8NOTE 4.000%12/01,250,000$1,321,000thousands by filing date
INFINERA CORP45667GAC7BOND1,500,000$1,100,000thousands by filing date
EXACT SCIENCES CORP30063PAA3NOTE 1.000% 1/11,000,000$1,090,000thousands by filing date
PACIRA BIOSCIENCES695127AD2NOTE 2.375% 4/01,000,000$998,000thousands by filing date
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/11,100,000$984,000thousands by filing date
II VI INC902104AB4NOTE 0.250% 9/01,000,000$968,000thousands by filing date
TEAM INC878155AE0NOTE 5.000% 8/0967,000$964,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339AA3NOTE 2.500% 2/01,000,000$800,000thousands by filing date
VEECO INSTRS INC DEL922417AD2NOTE 2.700% 1/11,000,000$747,000thousands by filing date
DEXCOM INC252131AF4NOTE 0.750% 5/1525,000$705,000thousands by filing date
NOVAVAX INC670002AB0NOTE 3.750% 2/01,000,000$613,000thousands by filing date
SILVER STD RES INC82823LAC0NOTE 2.875% 2/0520,000$516,000thousands by filing date
THERAVANCE BIOPHARMA88339KAA0NOTE 3.250%11/0500,000$514,000thousands by filing date
FLEXION THERAPEUTICS INC33938JAB2NOTE625,000$508,000thousands by filing date
NEW MTN FIN CORP647551AC4BOND500,000$485,000thousands by filing date
MANDIANT INC31816QAD3NOTE 1.625% 6/0500,000$457,000thousands by filing date
AVID TECHNOLOGY INC05367PAB6NOTE 2.000% 6/1500,000$448,000thousands by filing date
ENCORE CAP EUROPE FIN LTD29260UAA5BOND500,000$398,000thousands by filing date
TIMKENSTEEL CORP887399AA1CONVERTIBLE BOND365,000$380,000thousands by filing date
Global Eagle Entertainment37951DAB8CONV BOND500,000$375,000thousands by filing date
INSMED INC457669AA7NOTE 1.750% 1/1500,000$355,000thousands by filing date
Aceto Corp004446AD2CONV BOND500,000$355,000thousands by filing date
FLUIDIGM CORP DEL34385PAD0NOTE 2.750 2/0305,000$347,000thousands by filing date
ENCORE CAP GROUP INC292554AH5NOTE 2.875% 3/1400,000$334,000thousands by filing date
ENCORE CAP GROUP INC292554AF9NOTE 3.000% 7/0247,000$221,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062993-19-000383this filing2019-01-29acceptance time not in the bulk data set